Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q53006399)
Watch
English
Interpreting the efficacy findings in the CATIE study: what clinicians should know.
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16816796
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16816796%20AND%20SRC:MED&resulttype=core&format=json
retrieved
26 December 2019
title
Interpreting the efficacy findings in the CATIE study: what clinicians should know
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16816796
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16816796%20AND%20SRC:MED&resulttype=core&format=json
retrieved
26 December 2019
author name string
Herbert Y Meltzer
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16816796
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16816796%20AND%20SRC:MED&resulttype=core&format=json
retrieved
26 December 2019
William V Bobo
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16816796
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16816796%20AND%20SRC:MED&resulttype=core&format=json
retrieved
26 December 2019
publication date
1 July 2006
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16816796
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16816796%20AND%20SRC:MED&resulttype=core&format=json
retrieved
26 December 2019
published in
C N S Spectrums
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16816796
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16816796%20AND%20SRC:MED&resulttype=core&format=json
retrieved
26 December 2019
volume
11
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16816796
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16816796%20AND%20SRC:MED&resulttype=core&format=json
retrieved
26 December 2019
issue
7 Suppl 7
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16816796
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16816796%20AND%20SRC:MED&resulttype=core&format=json
retrieved
26 December 2019
page(s)
14-24
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16816796
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16816796%20AND%20SRC:MED&resulttype=core&format=json
retrieved
26 December 2019
cites work
Melperone in the treatment of neuroleptic-resistant schizophrenia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS109285290002664X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Olanzapine versus ziprasidone: results of a 28-week double-blind study in patients with schizophrenia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS109285290002664X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Are the new antipsychotics no better than the classical neuroleptics? The problematic answer from the CATIE study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS109285290002664X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Novel antipsychotics in the long-term treatment of schizophrenia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS109285290002664X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tardive dyskinesia in the era of typical and atypical antipsychotics. Part 2: Incidence and management strategies in patients with schizophrenia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS109285290002664X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Olanzapine versus placebo and haloperidol: acute phase results of the North American double-blind olanzapine trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS109285290002664X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Assessing clinical and functional outcomes in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS109285290002664X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS109285290002664X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Olanzapine versus haloperidol: acute phase results of the international double-blind olanzapine trial.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS109285290002664X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Patients' opinions of olanzapine and risperidone following long-term treatment: results from a cross-sectional survey
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS109285290002664X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term maintenance therapy with quetiapine versus haloperidol decanoate in patients with schizophrenia or schizoaffective disorder.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS109285290002664X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS109285290002664X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Consensus development conference on antipsychotic drugs and obesity and diabetes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS109285290002664X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The positive and negative syndrome scale (PANSS) for schizophrenia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS109285290002664X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Science to services: consumers need "real-world" science
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS109285290002664X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS109285290002664X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS109285290002664X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS109285290002664X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Should the CATIE study be a wake-up call?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS109285290002664X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Neurocognitive assessment in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project schizophrenia trial: development, methodology, and rationale
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS109285290002664X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS109285290002664X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A comparison of two doses of melperone, an atypical antipsychotic drug, in the treatment of schizophrenia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS109285290002664X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment-resistant schizophrenia--the role of clozapine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS109285290002664X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS109285290002664X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The dosing of atypical antipsychotics
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS109285290002664X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Dose response and dose equivalence of antipsychotics
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS109285290002664X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effectiveness of antipsychotic therapy in a naturalistic setting: a comparison between risperidone, perphenazine, and haloperidol
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS109285290002664X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Generating evidence to inform policy and practice: the example of the second generation "atypical" antipsychotics
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS109285290002664X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS109285290002664X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
First-episode psychosis: psychopathology, quality of life, and functional outcome
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS109285290002664X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Focus on the metabolic consequences of long-term treatment with olanzapine, quetiapine and risperidone: are there differences?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS109285290002664X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Metabolic dysregulation with atypical antipsychotics occurs in the absence of underlying disease: a placebo-controlled study of olanzapine and risperidone in dogs
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS109285290002664X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The choice of antipsychotic drugs for schizophrenia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS109285290002664X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Assessing the value of antipsychotics for treating schizophrenia: the importance of evaluating and interpreting the clinical significance of individual service costs
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS109285290002664X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The current status of tardive dyskinesia.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS109285290002664X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS109285290002664X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Estimating the costs and benefits of new drug therapies: atypical antipsychotic drugs for schizophrenia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS109285290002664X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Risperidone versus haloperidol in the treatment of chronic schizophrenic inpatients: a multicentre double-blind comparative study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS109285290002664X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS109285290002664X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS109285290002664X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy vs. effectiveness in psychiatric research.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS109285290002664X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1017/S109285290002664X
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16816796
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16816796%20AND%20SRC:MED&resulttype=core&format=json
retrieved
26 December 2019
PubMed publication ID
16816796
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16816796
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16816796%20AND%20SRC:MED&resulttype=core&format=json
retrieved
26 December 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit